TABLE 4.
Outcome | Predictor | p‐value | OR; 95% CI | |
---|---|---|---|---|
IPs | Mortality | PT <50% | 0.001 | 2.42; 1.43–4.08 |
Rebleeding | 0.004 | 2.13; 1.27–3.56 | ||
Rebleeding | GBS >11 | 0.009 | 1.85; 1.17–2.94 | |
Active bleeding | 0.01 | 1.82; 1.15–2.89 | ||
Sex, female | 0.016 | 1.76; 1.11–2.79 | ||
OPs | Mortality | Rebleeding | <0.0001 | 3.16; 2.02–4.94 |
Pre‐RS >5 | <0.0001 | 2.67; 1.66–4.30 | ||
Charlson >3 | <0.0001 | 2.29; 1.50–3.50 | ||
Haemodynamic instability | 0.014 | 1.93; 1.14–3.26 | ||
Cirrhosis | 0.014 | 2.28; 1.18–4.41 | ||
Anti‐platelets | 0.028 | 0.45; 0.22–0.92 | ||
Rebleeding | Active bleeding | <0.0001 | 2.14; 1.53–2.99 | |
Hb <8 g/dl | 0.02 | 1.48; 1.06–2.06 | ||
Charlson >3 | 0.04 | 1.47; 1.02–2.12 |
Abbreviations: CI, confidence interval; GBS, Glasgow‐Blatchford score; Hb, haemoglobin; OR, odds ratio; Pre‐RS, pre‐endoscopic Rockall Score; PT, prothrombin time.